sinc
first
report
middl
east
middl
east
respiratori
syndromecoronaviru
merscov
becom
global
concern
due
high
morbid
mortal
individu
infect
viru
although
major
merscov
case
report
saudi
arabia
overal
risk
area
outsid
middl
east
remain
signific
insid
saudi
arabia
addit
pandem
merscov
expect
thu
novel
tool
reagent
therapi
diagnosi
urgent
need
use
phage
display
develop
novel
monoclon
antibodi
mab
target
merscov
human
fab
phage
display
librari
pan
subunit
merscov
spike
protein
yield
three
uniqu
fab
fab
moder
appar
affin
half
maxim
effect
concentr
ec
nm
show
crossreact
spike
protein
cov
nonaggreg
thermost
c
reformat
fab
igg
immunoglobulin
gs
greatli
increas
appar
affin
k
nm
presum
due
effect
avid
appar
affin
notabl
higher
previous
report
antimerscov
refer
mab
k
nm
furthermor
two
three
mab
bound
merscov
erasmu
medic
center
emc
cov
reflect
high
bind
specif
howev
mab
lack
merscov
neutral
activ
given
high
affin
specif
desir
stabil
anticip
antimerscov
mab
would
suitabl
reagent
develop
antibodybas
diagnost
laboratori
hospit
set
pointofcar
test
antibodi
initi
south
korea
outbreak
still
sporad
occur
variou
region
includ
middl
east
merscov
caus
sever
respiratori
symptom
accompani
high
fever
cough
sever
pneumonia
mortal
rate
high
overal
risk
area
outsid
saudi
arabia
countri
case
report
remain
signific
insid
saudi
arabia
thu
novel
tool
reagent
therapi
diagnosi
urgent
need
among
four
coronaviru
genera
alpha
beta
gamma
delta
merscov
along
sever
acut
respiratori
syndrom
coronaviru
sarscov
belong
betacoronavirus
merscov
envelop
rna
viru
positivesens
singlestrand
rna
genom
encod
structur
protein
includ
spike
protein
nucleocapsid
protein
np
like
coronavirus
protein
present
surfac
merscov
virion
play
critic
role
viral
entri
host
cell
protein
consist
two
noncoval
associ
subunit
trimer
form
prefus
spike
upon
entri
viru
cell
receptorbind
domain
rbd
subunit
recogn
host
cell
receptor
dipeptidyl
peptidas
subunit
role
viral
fusion
host
cell
membran
interplay
two
heptad
repeat
transmembran
domain
subunit
vaccin
effect
prophylact
tool
viral
infect
although
long
develop
time
inabl
confer
immedi
protect
therapi
signific
drawback
neutral
monoclon
antibodi
mab
rapidli
emerg
altern
approach
complement
vaccin
viral
infect
due
critic
role
interact
host
cell
receptor
tremend
effort
focus
discoveri
neutral
mab
rbd
merscov
subunit
strategi
includ
phage
yeast
display
librari
select
immun
anim
human
mice
dromedari
camel
antibodi
isol
human
survivor
merscov
infect
howev
drawback
mab
costli
timeconsum
product
mammalian
cell
line
moreov
virus
easili
evolv
gener
rbd
variant
mutat
avoid
immun
respons
howev
mutat
less
common
subunit
make
attract
target
therapeut
purpos
inde
first
merscov
subunit
target
antibodi
call
gener
use
mous
immun
demonstr
recogn
variabl
loop
connector
domain
neutral
infect
viru
although
antimerscov
therapi
urgent
need
current
antivir
drug
vaccin
approv
human
use
therefor
import
develop
reliabl
diagnost
test
rapidli
becom
clear
manag
control
viral
spread
inde
variou
diagnost
test
develop
sinc
first
descript
viru
realtim
pcr
rtpcr
accompani
viral
rna
sequenc
primari
method
use
detect
viral
infect
although
obviou
limit
test
long
turnaround
time
serolog
test
reli
antibodi
specif
viral
antigen
np
also
use
either
captur
viral
antigen
enzymelink
immunosorb
assay
elisa
immunochromatograph
test
ict
detect
antimerscov
antibodi
elisa
indirect
fluoresc
antibodi
assay
ifa
western
blot
neutral
assay
studi
pan
synthet
human
fab
phage
display
librari
obtain
monoclon
antibodi
mab
specif
detect
viral
subunit
also
describ
use
mab
develop
novel
elisa
format
call
accel
anticip
use
rapid
diagnost
test
high
sensit
pointofcar
test
poct
merscov
infect
sinc
first
report
isol
patient
saudi
arabia
middl
east
respiratori
syndrom
coronaviru
merscov
pose
global
threat
public
health
pandem
outbreak
inhous
produc
human
synthet
fab
phage
display
librari
kfabi
built
human
germlinebas
scaffold
random
complementaritydetermin
region
cdr
unpublish
data
use
select
specif
binder
subunit
merscov
spike
protein
provid
dr
lee
kcdc
korea
center
diseas
control
cheongjusi
chungcheongbukdo
republ
korea
briefli
describ
product
amino
acid
amino
acid
tag
ctermin
express
insect
cell
use
recombin
baculoviru
ab
vector
san
diego
ca
usa
purifi
use
histrap
hp
ninta
affin
chromatographi
ge
healthcar
uppsala
sweden
hiload
superdex
size
exclus
chromatographi
ge
healthcar
briefli
perform
pan
immobil
immunotub
nunc
rochest
ny
usa
concentr
pb
phosphatebuff
salin
ph
c
h
rins
twice
tap
water
immunotub
block
skim
milk
pb
h
room
temperatur
rt
time
phage
librari
incub
skim
milk
pb
h
rt
block
phage
transfer
immunotub
coat
incub
h
c
wash
three
time
pbst
pb
contain
tween
bound
phage
elut
immunotub
mm
triethylamin
min
rt
follow
neutral
trishcl
ph
neutral
elut
phage
transfer
midlogphas
escherichia
coli
e
coli
cell
incub
h
c
gentl
rotat
rpm
infect
cell
spread
yt
agar
plate
supplement
glucos
ampicillin
incub
overnight
c
coloni
collect
via
scrape
ml
yt
medium
total
ml
yt
supplement
glucos
ampicillin
inocul
scrape
cell
yield
od
optic
densiti
nm
incub
c
shake
rpm
od
reach
cultur
infect
helper
phage
deriv
helper
phage
provid
dr
hong
kangwon
nation
univers
chuncheonsi
gangwondo
republ
korea
multipl
infect
incub
h
c
gentl
rotat
rpm
kanamycin
ad
final
concentr
cultur
grown
overnight
c
shake
rpm
cell
centrifug
g
min
supernat
pass
filter
phage
particl
precipit
use
onefifth
volum
precipit
buffer
polyethylen
glycol
peg
sigmaaldrich
st
loui
mo
usa
nacl
min
ice
precipit
phage
pellet
use
centrifug
g
min
resuspend
pb
phage
suspens
use
next
round
pan
stringent
select
number
wash
step
gradual
increas
amount
antigen
immobil
decreas
first
second
third
pb
ml
monoclon
phage
elisa
perform
three
round
pan
sever
halfarea
micropl
corn
new
york
ny
usa
coat
overnight
c
per
well
well
block
skim
milk
pb
h
rt
amplifi
phage
individu
clone
third
round
pan
ad
incub
h
c
wash
four
time
pbst
horseradish
peroxidas
hrp
conjug
antibodi
sino
biolog
beij
china
incub
h
c
wash
four
time
pbst
tmb
substrat
solut
sigmaaldrich
ad
min
reaction
stop
n
sulfur
acid
merck
darmstadt
germani
absorb
measur
nm
use
spectramax
micropl
reader
molecular
devic
sunnydal
ca
usa
demonstr
specif
monoclon
phage
elisa
perform
sarscov
spike
protein
abcam
cambridg
uk
human
coronaviru
spike
protein
sino
biolog
control
inhous
bacteri
express
vector
pkfab
use
construct
fab
express
vector
encod
tag
ctermin
streptag
fab
fragment
gene
amplifi
use
polymeras
chain
reaction
pcr
pcr
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
hilden
germani
digest
sfii
new
england
biolab
ipswich
usa
digest
product
separ
agaros
gel
singl
band
purifi
qiaquick
gel
extract
kit
qiagen
hilden
germani
fragment
ligat
similarlydigest
vector
fragment
use
dna
ligas
new
england
biolab
follow
transform
e
coli
compet
cell
enzynom
daejeon
korea
transform
ligat
mixtur
individu
coloni
transform
cell
isol
sequenc
isol
clone
verifi
compet
cell
invitrogen
carlsbad
ca
usa
transform
fab
express
vector
transform
grown
ml
terrif
broth
tb
media
supplement
ampicillin
c
shake
rpm
od
reach
logphas
cultur
induc
mm
isopropyl
iptg
incub
overnight
c
shake
rpm
cell
collect
resuspend
ml
te
mm
trishcl
mm
ethylenediaminetetraacet
acid
edta
sucros
ph
incub
min
ice
ml
te
ad
incub
h
ice
periplasm
fraction
collect
centrifug
g
min
filter
filter
periplasm
extract
load
column
pack
ml
streptactin
xt
iba
lifesci
goettingen
germani
column
wash
column
volum
cv
buffer
w
iba
lifesci
elut
cv
buffer
bxt
iba
lifesci
elut
protein
concentr
bufferexchang
pb
use
amicon
centrifug
filter
unit
millipor
carrigtwohil
co
cork
ireland
sever
halfarea
micropl
coat
overnight
c
per
well
rins
twice
tap
water
well
block
skim
milk
pb
h
rt
serial
dilut
sterptag
fab
ad
incub
h
c
wash
four
time
pbst
hrpconjug
strepmabclass
iba
lifesci
ad
plate
incub
h
c
wash
four
time
pbst
tmb
substrat
solut
incub
min
reaction
stop
n
sulfur
acid
absorb
measur
nm
use
spectramax
micropl
reader
plot
creat
use
fourparamet
curv
fit
algorithm
half
maxim
effect
concentr
ec
valu
determin
accordingli
well
microamp
fast
optic
reaction
plate
appli
biosystem
foster
citi
ca
usa
fab
protein
thermal
shift
dye
appli
biosystem
foster
citi
ca
usa
ad
neg
control
pb
mix
protein
thermal
shift
dye
plate
seal
microamp
optic
adhes
film
appli
biosystem
foster
citi
ca
usa
centrifug
g
min
measur
perform
use
realtim
pcr
instrument
instrument
set
accord
manufactur
instruct
experi
perform
least
triplic
light
heavi
chain
vector
poptivec
respect
use
herceptin
express
use
backbon
vector
vl
vh
cl
light
chain
variabl
domain
heavi
chain
variabl
domain
light
chain
constant
domain
respect
gene
individu
amplifi
use
pcr
vl
cl
use
overlap
extens
pcr
pcr
product
vlcl
vh
purifi
qiaquick
pcr
purif
kit
qiagen
hilden
germani
digest
follow
restrict
enzym
new
england
biolab
vlclsfii
ecori
vhsfii
nhei
digest
product
separ
agaros
gel
singl
band
purifi
qiaquick
gel
extract
kit
qiagen
hilden
germani
fragment
clone
e
coli
describ
section
individu
coloni
transform
cell
isol
sequenc
isol
clone
verifi
cell
cultur
express
medium
thermo
fisher
scientif
waltham
usa
humidifi
co
incub
c
shake
rpm
day
transfect
cell
densiti
approxim
cellsml
transfect
perform
use
polyethylenimin
pei
polysci
nile
il
usa
accord
manufactur
protocol
igg
antibodi
affinitypurifi
use
hitrap
mabselect
sure
ge
healthcar
pittsburgh
pa
usa
column
briefli
equilibr
carri
use
buffer
pb
ph
sampl
load
onto
equilibr
column
follow
sampl
load
column
wash
buffer
stabl
baselin
establish
follow
wash
step
protein
elut
buffer
b
glycin
ph
follow
elut
igg
brought
neutral
ph
tri
base
ph
dialyz
pb
gel
thermo
fisher
scientif
purifi
bufferexchang
igg
sampl
separ
bistri
gel
thermo
fisher
scientif
stain
sungel
stain
solut
lp
solut
deajeon
korea
separ
antibodi
use
sizeexclus
chromatographi
accomplish
use
water
allianc
water
milford
usa
connect
biosuit
high
resolut
sec
column
mm
mm
particl
size
water
milford
usa
separ
perform
use
isocrat
elut
pb
ph
flow
rate
mlmin
effluent
detect
uvvi
detector
nm
intact
mass
antibodi
determin
use
reversephas
chromatographi
separ
separ
intact
mass
accomplish
use
water
acquiti
class
uplc
system
water
milford
usa
connect
thermo
mabpac
tm
rp
column
mm
mm
particl
size
thermo
fisher
scientif
separ
perform
eluent
consist
formic
acid
water
eluent
b
consist
formic
acid
acetonitril
flow
rate
mlmin
gradient
fix
min
eluent
b
linearli
increas
min
eluent
b
effluent
analyz
water
synapt
hdm
system
quantiti
mgml
antibodi
mix
unitsml
pngasef
new
england
biolab
react
overnight
c
nativ
pngaseftr
antibodi
inject
sampl
cell
cultur
eightwel
chamber
slide
thermo
fisher
scientif
nunc
rockild
denmark
vero
cell
infect
merscov
erasmu
emc
strain
kindli
provid
erasmu
univers
netherland
cell
infect
human
coronavirus
hcov
strain
atcc
manassa
va
usa
strain
atcc
cell
infect
hcov
strain
isol
korean
patient
cytopathogen
effect
appear
infect
cell
cell
fix
methanol
pb
thermo
fisher
scientif
wa
usa
rabbit
polyclon
spike
protein
antibodi
sino
biolog
also
incub
cell
infect
hcov
strain
cell
infect
hcov
strain
type
cell
use
posit
control
immunofluoresc
assay
perform
without
posit
primari
antibodi
describ
use
neg
control
incub
primari
antibodi
cell
wash
tb
solut
secondari
antibodi
fluorescein
isothiocyan
fitc
conjug
goat
antihumanigg
abcam
fitcconjug
goat
antirabbitigg
abcam
fitcconjug
goat
antimouseigg
jackson
immunoresearch
west
grove
pa
usa
ad
cell
incub
cover
slip
ad
top
cell
fluoresc
mount
medium
dako
carpinteria
ca
usa
cover
cell
cell
observ
imag
obtain
use
fluoresc
microscop
nikon
eclips
tiu
intensilight
chgfi
nikon
tokyo
japan
bind
antibodi
assay
use
biacor
instrument
ge
healthcar
chicago
il
usa
antihistidin
antibodi
captur
kit
ge
healthcar
aminecoupl
activ
refer
flow
cell
sensor
chip
ge
healthcar
accord
manufactur
instruct
immobil
level
rang
ru
reson
unit
ru
use
similar
level
activ
refer
flow
cell
histidinetag
inject
use
flow
rate
activ
flow
cell
captur
level
rang
ru
ru
obtain
kinet
studi
igg
igg
concentr
rang
nm
nm
dilut
hbsep
buffer
ge
healthcar
experi
perform
c
associ
time
min
dissoci
time
min
flow
rate
bind
cycl
regener
solut
mm
glycin
ph
inject
min
flow
rate
remov
noncoval
bound
protein
signal
detect
rate
signal
per
second
bind
constant
determin
use
bind
model
bia
evalu
softwar
version
ge
healthcar
serial
fourfolddilut
mab
equal
volum
viru
plaqu
form
unit
pfu
well
incub
c
h
mixtur
ad
well
plate
seed
vero
cell
cellswel
incub
c
h
one
millilit
carboxymethylcellulos
within
medium
overlaid
cell
day
incub
cell
fix
paraformaldehyd
stain
crystal
violet
visual
plaqu
human
monoclon
antibodi
kcdc
cheongjusi
chungcheongbukdo
republ
korea
use
posit
control
neutral
merscov
infect
accel
plate
coat
overnight
c
per
well
igg
rins
five
time
pbst
well
block
skim
milk
pb
h
rt
rabbit
antimerscov
antibodi
sino
biolog
serial
twofolddilut
hrpconjug
goat
antirabbit
antibodi
sigma
aldrich
ad
incub
min
rt
wash
five
time
pbst
tmb
substrat
solut
ad
min
reaction
stop
n
sulfur
acid
absorb
measur
nm
use
thermo
scientif
multiskan
go
micropl
reader
thermo
fisher
scientif
standard
curv
creat
loglog
plot
use
linear
regress
algorithm
limit
detect
lod
calcul
concentr
gave
best
linear
ie
plot
equat
x
valu
lod
calcul
valu
averag
absorb
zero
concentr
sd
standard
deviat
recent
construct
synthet
human
fab
phage
display
librari
size
base
human
germlinebas
framework
region
fr
scaffold
carri
highli
diversifi
complementaritydetermin
region
cdr
human
antibodi
heavi
light
chain
unpublish
data
order
isol
human
antibodi
specif
recogn
phage
display
librari
pan
recombin
provid
dr
lee
kcdc
immobil
microtit
plate
follow
evalu
monoclon
phage
third
round
pan
elisa
figur
figur
twentyf
individu
clone
elisa
readout
least
four
time
background
level
skim
milk
consid
potenti
binder
fourteen
clone
sequenc
determin
complet
infram
remain
clone
contain
mutat
stop
codon
frameshift
data
shown
complementaritydetermin
region
cdr
human
antibodi
heavi
light
chain
unpublish
data
order
isol
human
antibodi
specif
recogn
phage
display
librari
pan
recombin
provid
dr
lee
kcdc
immobil
microtit
plate
follow
evalu
monoclon
phage
third
round
pan
elisa
figur
figur
twentyf
individu
clone
elisa
readout
least
four
time
background
level
skim
milk
consid
potenti
binder
fourteen
clone
sequenc
determin
complet
infram
remain
clone
contain
mutat
stop
codon
frameshift
data
shown
although
share
amino
acid
ident
human
coronavirus
hcov
sarscov
respect
tabl
investig
whether
fab
could
crossreact
hcov
protein
address
clone
analyz
use
phage
elisa
recombin
protein
sarscov
see
materi
method
result
show
fab
bind
cov
spike
protein
monospecif
figur
analyz
cdr
sequenc
clone
three
uniqu
fab
clone
fab
fab
fab
identifi
one
clone
fab
dominantli
select
via
pan
sequenc
two
clone
fab
fab
present
lower
frequenc
figur
figur
clone
repres
fab
fab
clone
repres
fab
monitor
phage
titer
three
round
pan
black
gray
bar
indic
ratio
phage
output
input
titer
present
percentag
pan
nonimmobil
surfac
respect
ratio
output
input
phage
output
titer
phage
input
titer
b
phage
elisa
perform
sarscov
spike
protein
cov
spike
proteinimmobil
surfac
blue
red
green
respect
c
amino
acid
sequenc
three
uniqu
clone
identifi
pan
left
rel
frequenc
right
sequenc
align
use
kabat
number
system
elisa
enzymelink
immunosorb
assay
middl
east
respiratori
syndromecov
subunit
protein
sarssp
sever
acut
respiratori
syndromecov
protein
hcov
protein
cov
coronaviru
cdr
complementaritydetermin
region
fr
framework
region
produc
character
binder
fab
protein
select
sequenc
clone
inhous
bacteri
express
vector
pkfab
fab
express
bacteria
cov
spike
proteinimmobil
surfac
blue
red
green
respect
c
amino
acid
sequenc
three
uniqu
clone
identifi
pan
left
rel
frequenc
right
sequenc
align
use
kabat
number
system
elisa
enzymelink
immunosorb
assay
middl
east
respiratori
syndromecov
subunit
protein
sarssp
sever
acut
respiratori
syndromecov
protein
hcov
protein
cov
coronaviru
cdr
complementaritydetermin
region
fr
framework
region
although
share
amino
acid
ident
human
coronavirus
hcov
sarscov
respect
tabl
investig
whether
fab
could
crossreact
hcov
protein
address
clone
analyz
use
phage
elisa
recombin
protein
sarscov
see
materi
method
result
show
fab
bind
cov
spike
protein
monospecif
figur
analyz
cdr
sequenc
clone
three
uniqu
fab
clone
fab
fab
fab
identifi
one
clone
fab
dominantli
select
via
pan
sequenc
two
clone
fab
fab
present
lower
frequenc
figur
figur
clone
repres
fab
fab
clone
repres
fab
produc
character
binder
fab
protein
select
sequenc
clone
inhous
bacteri
express
vector
pkfab
fab
express
bacteria
subsequ
purifi
result
fab
highli
pure
protein
yield
mgl
mgl
mgl
fab
fab
fab
respect
figur
tabl
subsequ
purifi
result
fab
highli
pure
protein
yield
mgl
mgl
mgl
fab
fab
fab
respect
figur
tabl
two
fab
protein
fab
fab
observ
monomer
visibl
highmolecularweight
hwm
aggreg
sizeexclus
chromatographi
figur
howev
fab
elut
much
later
sizeexclus
chromatographi
compar
two
fab
figur
although
fab
show
similar
migrat
behavior
two
fab
sdspage
analysi
figur
suggest
abnorm
retent
time
sizeexclus
chromatographi
seem
due
degrad
fab
protein
lead
smaller
fragment
rather
due
aggreg
sticki
natur
melt
temperatur
tm
fab
protein
measur
use
protein
thermal
shift
pt
assay
result
show
fab
least
stabl
tm
fab
fab
higher
tm
valu
respect
figur
tabl
appar
affin
fab
assess
use
elisa
nm
fab
moder
affin
subunit
nm
nm
nm
fab
fab
fab
respect
figur
tabl
two
fab
protein
fab
fab
observ
monomer
visibl
highmolecularweight
hwm
aggreg
sizeexclus
chromatographi
figur
howev
fab
elut
much
later
sizeexclus
chromatographi
compar
two
fab
figur
although
fab
show
similar
migrat
behavior
two
fab
sdspage
analysi
figur
suggest
abnorm
retent
time
sizeexclus
chromatographi
seem
due
degrad
fab
protein
lead
smaller
fragment
rather
due
aggreg
sticki
natur
melt
temperatur
c
fab
protein
measur
use
protein
thermal
shift
pt
assay
result
show
fab
least
stabl
c
fab
fab
higher
valu
c
c
respect
figur
tabl
appar
affin
fab
assess
use
elisa
ec
nm
fab
moder
affin
subunit
nm
nm
nm
fab
fab
fab
respect
figur
tabl
order
produc
character
fab
binder
igg
form
individu
vh
vl
sequenc
fab
clone
clone
heavi
fc
light
chain
express
vector
respect
igg
express
transient
cell
subsequ
purifi
shown
figur
result
igg
highli
pure
protein
yield
mgl
mgl
mgl
igg
igg
igg
respect
figur
tabl
order
produc
character
fab
binder
igg
form
individu
vh
vl
sequenc
fab
clone
clone
heavi
fc
light
chain
express
vector
respect
igg
express
transient
cell
subsequ
purifi
shown
figur
result
igg
highli
pure
protein
yield
mgl
mgl
mgl
igg
igg
igg
respect
figur
tabl
next
assess
whether
binder
specif
merscov
initi
demonstr
phage
elisa
immobil
spike
protein
figur
address
use
immunofluoresc
assay
shown
figur
igg
igg
specif
merscov
two
igg
antibodi
bound
merscov
show
indic
bind
coronaviru
strain
cell
line
test
figur
howev
igg
bind
coronaviru
strain
cell
line
appear
bind
nonspecif
vero
cell
use
merscov
infect
determin
whether
igg
igg
free
aggreg
analyz
use
sizeexclus
chromatographi
figur
igg
form
aggreg
igg
contain
high
molecular
weight
aggreg
figur
next
demonstr
whether
igg
antibodi
produc
intact
form
igg
igg
next
assess
whether
binder
specif
merscov
initi
demonstr
phage
elisa
immobil
spike
protein
figur
address
use
immunofluoresc
assay
shown
figur
igg
igg
specif
merscov
two
igg
antibodi
bound
merscov
show
indic
bind
coronaviru
strain
cell
line
test
figur
howev
igg
bind
coronaviru
strain
cell
line
appear
bind
nonspecif
vero
cell
use
merscov
infect
antibodi
igg
determin
use
biacor
shown
figur
igg
igg
show
pm
nm
appar
affin
respect
figur
tabl
experi
indic
signific
interact
occur
sinc
two
igg
antibodi
igg
igg
fail
neutral
merscov
ie
two
mab
could
prevent
merscov
infect
viral
infect
block
posit
control
mab
figur
investig
applic
reagent
detect
antimerscov
igg
serum
sampl
address
perform
proof
concept
studi
base
sandwich
immunoassay
use
accel
system
rapid
sensit
elisa
system
develop
plexens
inc
yonginsi
gyeonggido
republ
korea
igg
rabbit
polyclon
antimerscov
igg
use
antigen
captur
detect
reagent
respect
figur
first
three
differ
concentr
igg
employ
determin
one
provid
best
linear
good
fit
sandwich
accel
shown
figur
best
linear
r
obtain
igg
immobil
concentr
figur
condit
limit
detect
lod
detect
elisa
calcul
ngml
fmolml
figur
suggest
igg
appli
determin
whether
igg
igg
free
aggreg
analyz
use
sizeexclus
chromatographi
figur
igg
form
aggreg
igg
contain
high
molecular
weight
aggreg
figur
next
demonstr
whether
igg
antibodi
produc
intact
form
igg
igg
analyz
use
liquid
chromatographymass
spectrometri
lcm
without
pngase
f
treatment
result
confirm
observ
mass
within
da
theoret
mass
intact
igg
indic
igg
antibodi
produc
modif
figur
tabl
appar
bind
affin
k
igg
igg
determin
use
biacor
shown
figur
igg
igg
show
pm
nm
appar
affin
respect
figur
tabl
experi
indic
signific
interact
occur
sinc
two
igg
antibodi
igg
igg
fail
neutral
merscov
ie
two
mab
could
prevent
merscov
infect
viral
infect
block
posit
control
mab
figur
investig
applic
reagent
detect
antimerscov
igg
serum
sampl
address
perform
proof
concept
studi
base
sandwich
immunoassay
use
accel
system
rapid
sensit
elisa
system
develop
plexens
inc
yonginsi
gyeonggido
republ
korea
igg
rabbit
polyclon
antimerscov
igg
use
antigen
captur
detect
reagent
respect
figur
first
three
differ
concentr
igg
employ
determin
one
provid
best
linear
good
fit
sandwich
accel
shown
figur
best
linear
r
obtain
igg
immobil
concentr
figur
condit
limit
detect
lod
detect
elisa
calcul
ngml
fmolml
figur
suggest
igg
appli
accel
captur
reagent
diagnos
merscov
infect
detect
report
select
human
mab
specif
merscov
subunit
use
human
synthet
fab
phage
display
librari
phage
display
power
tool
use
discoveri
therapeut
applic
infecti
diseas
particular
phage
display
demonstr
highli
effect
select
human
antibodi
merscov
mostli
human
antibodi
phage
display
format
gener
human
peripher
blood
mononuclear
cell
pbmc
although
gener
human
mab
target
rbd
subunit
higher
neutral
potenc
target
region
protein
subunit
still
necessari
combin
human
mab
recogn
differ
neutral
epitop
due
emerg
virus
carri
rbd
mutat
mous
mab
mab
demonstr
bind
affin
nm
neutral
infect
pseudomerscov
bear
protein
recent
reveal
mab
recogn
connector
domain
present
domain
subunit
region
variabl
sequenc
length
among
betacoronavirus
although
two
mab
select
phage
display
librari
fail
neutral
infect
merscov
data
shown
repres
first
human
report
select
human
mab
specif
merscov
subunit
use
human
synthet
fab
phage
display
librari
phage
display
power
tool
use
discoveri
therapeut
applic
infecti
diseas
particular
phage
display
demonstr
highli
effect
select
human
antibodi
merscov
mostli
human
antibodi
phage
display
format
gener
human
peripher
blood
mononuclear
cell
pbmc
although
gener
human
mab
target
rbd
subunit
higher
neutral
potenc
target
region
protein
subunit
still
necessari
combin
human
mab
recogn
differ
neutral
epitop
due
emerg
virus
carri
rbd
mutat
mous
mab
mab
demonstr
bind
affin
nm
neutral
infect
pseudomerscov
bear
protein
recent
reveal
mab
recogn
connector
domain
present
domain
subunit
region
variabl
sequenc
length
among
betacoronavirus
although
two
mab
select
phage
display
librari
fail
neutral
infect
merscov
data
shown
repres
first
human
antibodi
target
select
human
synthet
phage
display
librari
moreov
desir
biophys
properti
term
affin
thermal
stabil
nonaggreg
essenti
develop
therapeut
diagnost
furthermor
reformat
fab
igg
highli
increas
appar
affin
k
dapp
seemingli
due
avid
effect
thu
antibodi
repres
valuabl
addit
subunittarget
mab
interest
reveal
bind
subunit
structur
studi
current
ongo
base
subnm
appar
affin
igg
specif
merscov
tri
develop
antibodi
captur
elisa
diagnosi
merscov
infect
first
elisabas
assay
employ
mab
elisa
test
use
accel
plexens
inc
rapid
sensit
elisa
system
well
elisa
plate
stack
layer
surfac
area
well
increas
result
higher
elisa
signal
protein
immobil
surfac
also
enabl
faster
develop
min
smaller
amount
reagent
due
effect
stack
inde
proof
concept
studi
igg
rabbit
polyclon
antimerscov
igg
demonstr
detect
limit
ngml
fmolml
previous
test
fab
determin
feasibl
use
mab
paperbas
analyt
devic
pad
design
captur
observ
mab
work
effect
pad
detect
limit
approxim
nm
fmolml
due
lack
detect
assay
compar
possibl
evalu
result
directli
howev
still
possibl
compar
result
indirectli
obtain
detect
assay
perform
use
nucleocapsid
protein
np
antigen
captur
elisabas
method
immunochromatograph
test
ict
similar
sarscov
np
protein
prefer
target
protein
mer
simpli
due
presenc
higher
copi
number
np
protein
protein
accord
previou
npbase
studi
recombin
np
captur
elisabas
method
show
detect
limit
ngml
fmolml
ngml
fmolml
use
ict
anoth
captur
elisa
yield
detect
limit
ngml
fmolml
highlight
fact
accel
system
perform
better
previous
develop
method
even
though
target
protein
differ
studi
current
underway
demonstr
whether
accel
feasibl
detect
virion
antimerscov
serum
identifi
detect
limit
tcid
ml
tcid
tissu
cultur
infect
dose
provid
direct
comparison
np
captur
elisabas
assay
would
also
interest
perform
accel
antinp
mab
compar
perform
quantit
way
accel
assay
also
could
appli
detect
igg
antivir
serum
sampl
merscovinfect
peopl
drawback
strategi
gener
antibodi
viru
appear
within
day
onset
ill
therefor
antibodi
might
fall
behind
detect
viral
genom
materi
use
molecular
method
rtpcr
thu
accel
assay
perform
combin
molecular
method
therebi
detect
viral
genom
front
line
diagnosi
viral
infect
diagnos
molecular
method
use
lower
respiratori
tract
sampl
viral
load
high
later
case
method
fail
detect
viral
genom
respiratori
sampl
elisa
assay
alon
possibl
combin
npbase
antigen
captur
assay
appli
confirm
diagnos
viral
infect
anoth
point
address
strategi
sinc
mab
human
antibodi
dehuman
avoid
fals
posit
due
bind
secondari
antihuman
antibodi
appli
assay
given
high
titer
antibodi
merscov
adult
dromedari
immedi
reservoir
merscov
transmiss
human
name
middl
east
present
antibodi
captur
elisa
may
potenti
use
detect
merscov
dromedari
anim
sampl
may
also
use
screen
anim
sampl
merscov
long
secondari
antibodi
detect
animalderiv
antibodi
avail
conclus
select
highaffin
human
mab
human
synthet
phage
display
librari
character
result
fab
igg
observ
high
affin
high
specif
merscov
desir
biophys
properti
properti
warrant
develop
test
igg
mab
accel
develop
first
antibodi
captur
assay
detect
limit
assay
surpass
previous
develop
npbase
antigen
captur
assay
refin
test
warrant
develop
rapid
sensit
detect
kit
point
care
test
fulllength
antibodi
sequenc
human
fab
patentpend
subject
matter
korea
patent
number
registr
date
april
follow
avail
onlin
http
figur
phage
elisa
surfac
phage
round
pan
figur
sizeexclus
chromatographi
analysi
fab
figur
intact
mass
analysi
igg
figur
merscov
neutral
assay
igg
tabl
sequenc
ident
similar
subunit
tabl
comparison
molecular
weight
theoret
mass
observ
mass
igg
